Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer

Multiple Cancer Types

This study will assess the safety and preliminary efficacy of duvelisib in combination with pembrolizumab in subjects with recurrent or metastatic (R / M) head and neck squamous cell carcinoma (HNSCC).
Head/Neck, Phase I
I/II
Gibson, Mike
NCT04193293
VICCHNP19109

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: